|
T.TH
|
On Linkedin, one of the person giving a thumb up to the poste about hiring at...
|
|
T.TH
|
Thera is not running clinical trial in oncology by themselves. This is...
|
|
T.TH
|
I found the relative expression of sortilin in different tissues of the human...
|
|
T.TH
|
One thing Thera did not explain, and I made some research about that on the...
|
|
T.TH
|
This incentive is BS. The SP will move up if they come up with really good...
|
|
T.TH
|
We know that now. That's what I said here every times there was...
|
|
T.TH
|
I don't understand why there is a discussion about where the phase Ia is...
|
|
T.TH
|
We can argue all we want, and we did, but only really good results in...
|
|
T.TH
|
I need to work on my Italian... https://vimeo.com/652538765
|
|
T.TH
|
I know we want the results in oncology here, but Thera won another award...
|
|
T.TH
|
To engage with investors effectively you need something meaningful to put...
|
|
T.TH
|
If a shareholder is so uninformed about a stock he owns, it is likeky that he...
|
|
T.TH
|
So put a PR out to tell us what we basicly already know. To what end? And all...
|
|
T.TH
|
They cannot get approval for all cancer types expressing sortilin. They need...
|
|
T.TH
|
New job offers on their website, also advertising it on Linkedin. https...
|
|
T.TH
|
One more thing, even though the study is for "all comers", I think...
|
|
T.TH
|
With Trodelvy having 33% response rate and 45% clinical benefit rate (those...
|
|
T.TH
|
Thera is nominated for an award about business innovation by "National...
|
|
T.TH
|
Today's news about the extension of the ATM is in line with results that...
|
|
T.TH
|
The big advantage of SN38, is that it is much more potent than irinotecan, an...
|